Growth Metrics

CVRx (CVRX) Return on Capital Employed (2021 - 2026)

CVRx's quarterly Return on Capital Employed came in at 10.69% in Q1 2026, down 762.0% year-on-year from 1.62% in Q1 2025, and up 9.52% quarter-over-quarter from 11.82% in Q4 2025.

CVRx has reported Return on Capital Employed for 6 years, with the latest figure at 10.69% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed fell 762.0% year-over-year to 10.69%; the trailing twelve-month figure through Mar 2026 stood at 10.69% (down 762.0% YoY), and the FY2025 full-year result was 10.59%, up 49.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 10.69%, up from 11.82% in the prior quarter.
  • The five-year high for Return on Capital Employed was 3.08% in Q1 2025, with the low at 60.24% in Q2 2024.
  • Average Return on Capital Employed over 5 years is 29.28%, with a median of 32.41% recorded in 2022.
  • Year-over-year, Return on Capital Employed slumped 2003 bps in 2022 and soared 5660 bps in 2025.
  • Tracing CVRX's Return on Capital Employed over 5 years: stood at 36.14% in 2022, then decreased by 16 bps to 41.87% in 2023, then surged by 75 bps to 10.5% in 2024, then slipped by 13 bps to 11.82% in 2025, then increased by 10 bps to 10.69% in 2026.
  • The last three Return on Capital Employed figures came in at 10.69% (Q1 2026), 11.82% (Q4 2025), and 3.31% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.61%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.24%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 7.36%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 7.62%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.30%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 11.57%
10 CVRx 144.43 Mn 72.13 Mn 12.88 Mn -10.69%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.69%
Dec 31, 2025 -11.82%
Sep 30, 2025 -3.31%
Jun 30, 2025 -3.65%
Mar 31, 2025 -3.08%
Dec 31, 2024 -10.50%
Sep 30, 2024 -58.36%
Jun 30, 2024 -60.24%
Mar 31, 2024 -51.98%
Dec 31, 2023 -41.87%
Sep 30, 2023 -43.49%
Jun 30, 2023 -41.42%
Mar 31, 2023 -38.65%
Dec 31, 2022 -36.14%
Sep 30, 2022 -32.41%
Jun 30, 2022 -27.76%
Mar 31, 2022 -22.31%
Dec 31, 2021 -16.11%
Sep 30, 2021 -17.63%